References
- AASMUNDSTAD, T. A., RIPEL, A., BODD, E., B.10NEBOE, A. and MoRLAND, J., 1993, Different biotransformation of morphine in isolated liver cells from guinea pig and rat. Biochemical Pharmacology, 46, 961–968.
- BLANCK, A., HANSSON, T., NÄSLUND, B. and RA, A., 1990, Sex differences and endocrine regulation of morphine oxidation in rat liver. Biochemical Pharmacology, 39, 1820–1822.
- CORREIA, M. A., KROWECH, G., CALDERA-MUONZ, P., YEE, S. L., STRAUB, K. and CASTAGNOLI, N. J., 1984a, Morphine metabolism revisited. II. Isolation and chemical characterization of a glutathionylmorphine adduct from rat liver preparations. Chemico-Biological Interactions, 51, 13–24.
- CORRELk, M. A., WONG, J. A. and SOLV1EN, E., 1984b, Morphine metabolism revisited. I. Metabolic activation of morphine to a reactive species in rats. Chemko-Biological Interactions, 49, 255–268. ExLow-LASTBOM, L., MOLDEUS, P. and ORRENIUS, S., 1986, On the mechanisms of glutathione depletion in hepatocytes exposed to morphine and ethylmorphine. Toxicology, 42, 13–21.
- EVANS, A. M. and SHANAHAN, K., 1995, The disposition of morphine and its metabolites in the in-situ rat isolated perfused liver. Journal of Pharmacy and Pharmacology, 47, 333–339.
- ISHDA, T., KUMAGAI, Y., IKEDA, Y., YANO, M., TOKI, S., MIHASHI, K., EUJIOKA, T., IwAsE, Y. and HACHIYAMA, S., 1989, (8S)-(glutathione-S-yl)dihydromorphinone, a novel metabolite of mor-phine from guinea pig bile. Drug Metabolism and Disposition, 17, 77–81.
- ISHIDA, T., YAMANO, S. and TOKI, S., 1981, Detection of morphinone as a new metabolite of morphine in guinea pig urine. In Advances in Endogenous and Exogenous Opioids, edited by H. Takagi and E. J. Simon (Tokyo: Kodansha), p. 481.
- JAMES, R. C., GOODMAN, D. R. and HARBISON, R. D., 1982, Hepatic glutathione and hepatoxicity: changes induced by selected narcotics. Journal of Pharmacology and Experimental Therapeutics, 221, 708–714.
- JAMES, R. C., WESSINGER, W. D., ROBERTS, S. M., MILLNER, G. C. and PAULE, M. G., 1988, Centrally mediated opioid induced depression of hepatic glutathione: effects of intracerbroventricular administration of mu, kappa, sigma, and delta agonists. Toxicology, 51, 267–279.
- KLUTCH, A., 1974, A chromatographic investigation of morphine metabolism in rats. Confirmation of N-demethylation of morphine and isolation of a new metabolite. Drug Metabolism and Disposition, 2, 23–30.
- KUMAGAI, Y., ISHIDA, T. and TOKI, S., 1987, Method for determination of morphinone in urine and bile of guinea-pig by high-performance liquid chromatography. Journal of Chromatography, 421, 155–160.
- KUMAGAI, Y., TODAKA, T. and Tom, S., 1990, A new metabolic pathway of morphine; in vivo and in vitro formation of morphinone and morphinone—glutathione adduct in guinea pig. Journal of Pharmacology and Experimental Therapeutics, 225, 504–510.
- Kuo, C. K., HANIOKA, N., HOSHIKAWA, Y., OGURI, K. and YOSHLMURA, H., 1991, Species difference of site-selective glucuronidation of morphine. Journal of Pharmacobio-Dyanamics, 14, 187–193.
- MILNE, R. W., NATION, R. L. and SOMOGYI, A. A., 1996, The disposition of morphine and its 3-and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metabolism Reviews, 28, 345–472.
- NAGAMATSU, K. and HASEGAW A., 1992, Covalent binding of morphine to isolated rat hepatocytes. Biochemical Pharmacology, 43, 2631–2635.
- NAGAMATSU, K., KIDO, Y., TERAO, T., ISHIDA, T. and TOKI, S., 1982a, Protective effect of sulfhydral compounds on acute toxicity of morphinone. Life Sciences, 30, 1121–1127.
- NAGAMATSU, K., KIDO, Y., TERAO, T., ISHIDA, T. and TOM, S., 1982b, Effect of morphinone on opiate binding and morphine-elicited analgesia. Life Sciences, 31, 1451–1457.
- NAGAMATSU, K., KIDO, Y., TERAO, T., ISHIDA, T. and TOKI, S., 1983, Studies on the mechanism of covalent binding of morphine metabolites to proteins in mouse. Drug Metabolism and Disposition, 11, 190–194.
- NAGAMATSU, K., OHNO, Y., IICEBUCHI, H., TAKAHASHI, A., TERAO, T. and TAKANAK A., 1986, Morphine metabolism in isolated rat hepatocytes and implications for hepatotoxicity. Biochemical Pharmacology, 35, 3543–3548.
- RAPOPORT, H., BAKER, D. R. and REIST, H. N., 1957, Morphinone. Journal of Organic Chemistry, 22, 1489–1492.
- RUSH, G. F., NEWTON, J. F. and HooK, J. B., 1983, Sex differences in the excretion of glucuronide conjugates: role of internal glucuronidation. Journal of Pharmacology and Experimental Thera-peutics, 227, 658–662.
- Sxouus, N. P., JAmEs, R. C., HARBISON, R. D. and ROBERTS, S. M., 1989a, Depression of hepatic glutathione by opioid analgesic drugs in mice. Toxicology and Applied Pharmacology, 99, 139-147. Sxouus, N. P., JAmEs, R. C., HARBISON, R. D. and ROBERTS, S. M., 1989b, Perturbation of glutathione by a central action of morphine. Toxicology, 57, 287–302.
- SKETT, P., 1988, Biomedical basis of sex differences in drug metabolism. Pharmacological Therapeutics, 38, 269–304.
- YAMANO, S., KAGEURA, E., ISHIDA, T. and TOKI, S., 1985, Purification and characterization of guinea pig liver morphine 6-dehydrogenase. Journal of Biological Chemistry, 260, 5259–5264.
- YAMANO, S., NISHIDA, F. and TOM, S., 1986, Guinea-pig liver morphine 6-dehydrogenase as a naloxone reductase. Biochemical Pharmacology, 35, 4321–4326.
- YEH, S. Y., KREBS, H. A. and GORODETTZKY, C. W., 1979, Isolation and identification of morphine N-oxide, a- and /3-dihydromorphines, /3-or y-isomorphine, and hydroxylated morphine as morphine metabolites in several mammalian species, Journal of Pharmaceutical Sciences, 68, 133–140.
- YEH, S. Y., McQuINN, R. L. and GORODETTZKY, C. W., 1977, Biotransformation of morphine to dihydromorphinone and normorphine in the mouse, rat, rabbit, guinea pig, cat, dog, and monkey. Drug Metabolism and Disposition, 5, 335–342.